Mersana Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid
Mersana Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid of $5.50 million as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-03-03
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $5.50M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $9.47M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $13.50M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $17.19M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2024-12-31 | $5.50M 10-K · filed 2025-03-03 |
| 2023-12-31 | $9.47M 10-K · filed 2024-02-28 |
| 2022-12-31 | $13.50M 10-K · filed 2023-02-28 |
| 2021-12-31 | $17.19M 10-K · filed 2022-02-28 |
| 2021-09-30 | $18.15M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $19.10M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $14.85M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $15.45M 10-K · filed 2021-02-26 |
| 2020-09-30 | $16.05M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $16.65M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $17.26M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $3.08M 10-K · filed 2020-02-28 |
| 2019-09-30 | $3.67M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $4.25M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $4.84M 10-Q · filed 2019-05-09 |